Research output per year
Research output per year
- 10 results
Search results
-
2022
High throughput metabolism related drug screening identifies hypoxia inducible factor-1 alpha as a promising therapeutic target in proteasome inhibitor resistant multiple myeloma
Weir, P., Besse, L., Besse, A., Driessen, C., McMullin, M. F., Crawford, L. & Donaldson, D., 25 Aug 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, Supplement, p. S99-S100 P-117.Research output: Contribution to journal › Meeting abstract › peer-review
-
2021
HUWE1 orchestrates DNA repair in response to replicative stress in Multiple Myeloma
Morgan, J., McAvera, R., Mills, K. & Crawford, L., 30 Sept 2021, In: Clinical Lymphoma, Myeloma and Leukemia. 21, p. S69 1 p., P-056.Research output: Contribution to journal › Meeting abstract › peer-review
-
TRIM33 Loss in Multiple Myeloma Impairs the DNA Damage Response Resulting in Sensitivity to PARP and ATR Inhibitors
McAvera, R. M., Morgan, J., Mills, K. & Crawford, L. J., 15 Dec 2021, In: Blood. 138, 1Research output: Contribution to journal › Meeting abstract › peer-review
-
TRIM33 loss in Multiple Myeloma is associated with defective DNA repair and sensitivity to PARP inhibition
McAvera, R., Morgan, J., Mills, K. & Crawford, L., 30 Sept 2021, In: Clinical Lymphoma, Myeloma and Leukemia. 21, p. S68 1 p., P-054.Research output: Contribution to journal › Meeting abstract › peer-review
-
2019
Dysregulation of HUWE1 is associated with an increased mutational burden in Multiple Myeloma
Morgan, J., McAvera, R., Mills, K. & Crawford, L., 18 Oct 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19, Suppl 10, p. e71-e71Research output: Contribution to journal › Meeting abstract › peer-review
-
Loss of TRIM33 in Multiple Myeloma correlates with increased genomic instability
McAvera, R., Morgan, J., Johnston, C., Mills, K. & Crawford, L., 18 Oct 2019, In: Clinical Lymphoma, Myeloma and Leukemia. 19, Suppl 10, p. e70-e71Research output: Contribution to journal › Meeting abstract › peer-review
-
2018
Relationship between HUWE1 mutation and functionality in Multiple Myeloma
Crawford, L., Campbell, D. & Irvine, A., 01 Dec 2018, In: Blood. 132, Suppl 1, p. 4512Research output: Contribution to journal › Meeting abstract › peer-review
-
2017
HUWE1 Inhibition as a Therapeutic Strategy to Target MYC in MM
Crawford, L. J., Chauhan, D. & Irvine, A. E., 07 Dec 2017, In: Blood. 130, Suppl 1, p. 3077Research output: Contribution to journal › Meeting abstract › peer-review
-
2016
The E3 ligase HUWE1 is a potential therapeutic target in Multiple Myeloma
Crawford, L. & Irvine, A., 01 Dec 2016, In: Blood. 128, 22, 240.Research output: Contribution to journal › Meeting abstract › peer-review
-
2007
Adiponectin is produced by lymphocytes and inhibits granulopoiesis.
Crawford, L., Peake, W., Price, S., Morris, T. & Irvine, A., 2007, In: HAEMATOLOGICA. 92, 163.Research output: Contribution to journal › Meeting abstract › peer-review